Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines

Lawrence L'Italien1, Marcel Tanudji, Loren Russell

  • 1Schering-Plough Biopharma, Palo Alto, California 94304, USA.

Insights

Cyclin-dependent kinases (CDK1) and CDK2 show functional redundancy in cancer cells. Ablating one kinase leads to compensatory shifts, masking essential roles and impacting cell cycle progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Previous studies questioned the essentiality of Cyclin-dependent kinase 2 (Cdk2).
  • Recent findings suggest Cdk1 compensates for Cdk2 during the G1/S transition in specific cell types.

Purpose of the Study:

  • To investigate potential redundant mechanisms between Cdk1 and Cdk2 in cancer cell lines.
  • To understand the functional consequences of ablating Cdk1 or Cdk2 on cell cycle progression.

Main Methods:

  • Utilized RNA interference (RNAi) to selectively knockdown Cdk1 and Cdk2 in multiple cancer cell lines.
  • Analyzed cyclin A and cyclin B redistribution patterns upon Cdk1 or Cdk2 ablation.
  • Assessed kinase activities of resulting cyclin-CDK complexes.

Main Results:

  • Observed complex redistribution of cyclin A to its reciprocal CDK partner upon single kinase ablation.
  • Demonstrated cyclin B redistribution to Cdk2 following Cdk1 knockdown, enhancing kinase activity.
  • Simultaneous knockdown of both Cdk1 and Cdk2 revealed significant G2 phase cell cycle arrest.

Conclusions:

  • A redundant mechanism between Cdk1 and Cdk2 exists at the G2 phase in cancer cells.
  • This redundancy masks the essential role of Cdk2 when singly ablated, contributing to cell cycle progression.
  • The distinct G2 arrest observed suggests differential CDK activity requirements for cell cycle progression in normal versus cancer cells.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...